Health
Results: 3853-3864 of 8222

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US

Aignostics Announces Results for Pathology Foundation Model Developed in Collaboration with Mayo Clinic








